Skip to main content
. 2014 Mar 25;5(9):2853–2863. doi: 10.18632/oncotarget.1854

Figure 5. SeC enhances DOX-induced growth inhibition of tumor xenografts.

Figure 5

Combined treatment inhibits tumor volume (A, B) and tumor weight (C) of HepG2 human hepatoma carcinoma xenografts in nude mice, but not affect body weight (D) of mice.